regadenoson

Known as: (1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide, Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)- 
An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVES The goal of this study was to compare regadenoson and dipyridamole hyperemia for quantitative myocardial perfusion… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Review
2013
Review
2013
Adenosine signalling has long been a target for drug development, with adenosine itself or its derivatives being used clinically… (More)
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2013
2013
Adenosine A2A receptor (A2AR) agonists reduce invariant natural killer T (iNKT) cell activation and decrease inflammation in… (More)
  • table 1
Is this relevant?
2011
2011
OBJECTIVES The aim of this study was to evaluate the efficacy of regadenoson, in comparison with adenosine, for assessing… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVES This study sought to determine whether regadenoson induces left ventricular perfusion defects of similar size and… (More)
Is this relevant?
2009
2009
BACKGROUND Adenosine and regadenoson increase heart rate (HR) when used as stress agents to produce coronary hyperemia due to… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVES To compare the effects of age, gender, body mass index, and diabetes on the safety and efficacy of regadenoson stress… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Earlier phase 1 and 2 studies have shown that regadenoson has desirable features as a stress agent for myocardial… (More)
  • table 1
Is this relevant?
2007
2007
The authors have investigated the pharmacokinetics and tolerability of regadenoson, a selective A2A adenosine receptor agonist… (More)
Is this relevant?
2001
2001
We investigated whether activation of A(1) or A(3) adenosine receptors (ARs) induces late preconditioning (PC) against infarction… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?